SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-000248
Filing Date
2020-01-06
Accepted
2020-01-06 17:24:09
Documents
4
Period of Report
2019-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 49700
2 ex3-1.htm EX-3.1 15842
3 ex10-1.htm EX-10.1 18886
4 ex10-1_001.jpg GRAPHIC 2971
  Complete submission text file 0001493152-20-000248.txt   90039
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36268 | Film No.: 20510955
SIC: 2835 In Vitro & In Vivo Diagnostic Substances